A researcher in Purdue University’s College of Science, USA, is developing a patent-pending platform technology that mimics the dual-layer structure...

Exosome-based therapy targets squamous cell carcinomas that are drug-resistant and offers new hope for patients with drug-resistant cancers

Exosome-based therapy targets squamous cell carcinomas that are drug-resistant and offers new hope for patients with drug-resistant cancers

Exosomes, which are excreted by all live cells, contain cell components such as DNA, RNA, medlinklipids/medlink, and proteins. When they are...

NEW YORK, Sept. 4, 2024. Immunic, Inc., a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...

LOS ALTOS, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing...

The strategic landscape of naval warfare has undergone a remarkable transformation over the past few decades, with nations increasingly focusing on...

Competitive + Benefits: Astellas Europe: You will be part of an inclusive team that works to develop innovative therapies for patients. Warsaw (PL)

The current high levels of carbon dioxide (CO2) emissions are a significant contributor to global warming. Cement-based materials have demonstrated...

Gene Therapies For Cardiomyopathies Market Gene Therapies For Cardiomyopathies Market Growth is expected due to increased interest from companies in...